Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with any type of solid tumour, confirmed by biopsy
- People whose cancer is at any stage or location, and who are scheduled to have surgery to remove the tumour all at once — including people with cancer that has come back or a new cancer that has developed
- People whose planned surgery is intended to cure the cancer, as part of standard medical care
- People aged 18 years or older, of any sex
- People who are expected to live for more than 12 weeks
- People who have a reasonably good level of physical functioning, as measured by standard medical scoring tools (confirm with trial site)
- People whose blood sugar level is below 200 mg/dL on the day of surgery, before the imaging substance is given
Who may not be able to join:
- People for whom surgery is not considered safe or suitable for any general or local medical reason
- People who are pregnant or breastfeeding
- People whose blood sugar level is 200 mg/dL or above before the imaging substance is given
- People who have taken part in another clinical trial or research study in the past year that involved more than a small amount of radiation exposure (1 mSv) — though the trial doctor may still consider people who received that level of radiation as part of their usual care, unless the lead researcher determines there may be a safety risk
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael Topf, MD, Vanderbilt University/Ingram Cancer Center
Phone: 615-936-2807
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The study will determine the feasibility of intraoperative high-resolution specimen PET-CT imaging in solid tumors.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.